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that is mediated by GABAergic inputs. By
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interneurons, Zhang et al. were able to
modulate both sensory and emotional
responses to neuropathic pain.
Cell Reports
ReportRole of Prelimbic GABAergic Circuits in
Sensory and Emotional Aspects of Neuropathic Pain
Zizhen Zhang,1,2,3 Vinicius M. Gadotti,1,2,3 Lina Chen,1,2,3 Ivana A. Souza,1,2,3 Patrick L. Stemkowski,1,2,3
and Gerald W. Zamponi1,2,3,*
1Department of Physiology and Pharmacology
2Hotchkiss Brain Institute
3Alberta Children’s Hospital Research Institute
Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada
*Correspondence: zamponi@ucalgary.ca
http://dx.doi.org/10.1016/j.celrep.2015.07.001
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
Noxious stimuli are detected by peripheral nocicep-
tors and then transmitted to higher CNS centers,
where they are perceived as an unpleasant sensa-
tion. The mechanisms that govern the emotional
component associated with pain are still incom-
pletely understood. Here, we used optogenetic ap-
proaches both in vitro and in vivo to address this
issue. We found that peripheral nerve injury inhibits
pyramidal cell firing in the prelimbic area of the pre-
frontal cortex as a result of feed-forward inhibition
mediated by parvalbumin-expressing GABAergic
interneurons. In addition, activation of inhibitory
archaerhodopsin or excitatory channelrhodopsin-2
in these neurons decreased and increased pain re-
sponses, respectively, in freely moving mice and
accordingly modulated conditioned place prefer-
ence scores and place escape/avoidance behavior.
Our findings thus demonstrate an important role of
the prelimbic area in sensory and emotional aspects
of pain and identify GABAergic circuits in this region
as a potential target for pain therapeutics.INTRODUCTION
Neuropathic pain can present as spontaneous (ongoing) discom-
fort in the absence of any observable stimulus or as a painful hy-
persensitivity to temperature and touch. The clinicalmanagement
of this condition remains difficult (Dworkin et al., 2007; Jongen
et al., 2014), and much effort has focused on interfering with
pain signals in the primary afferent pathway. In contrast, despite
a growing understanding of pain processing in higher brain re-
gions such as the anterior cingulate cortex (ACC) (Fuchs et al.,
2014; Zhuo, 2014), it has not yet been possible to exploit this
knowledge toward therapeutic intervention. The prefrontal cortex
(PFC) is in the center for modulating goal-directed behavior,
emotion, andcognitive functions andplays amajor role in control-
ling emotional and cognitive dimension of pain. Anatomical and752 Cell Reports 12, 752–759, August 4, 2015 ª2015 The Authorsphysiological evidence supports its role in pain perception (Devo-
ize et al., 2011). The modulatory function of the PFC in pain is
further illustrated by its role in placebo analgesia, and it has
been reported that the PFC undergoes anatomical and functional
reorganization during chronic pain conditions (Apkarian et al.,
2004;Metz et al., 2009). Indeed, neural imaging studies in humans
demonstratedenhancedneural activities (BOLDsignal) in thePFC
in chronic pain states (Apkarian et al., 2005;Moisset andBouhas-
sira, 2007), and in an arthritis model of persistent pain, deactiva-
tion of the PFC through increased inputs from the basal lateral
amygdala has been reported (Ji and Neugebauer, 2011; Ji et al.,
2010). How such reduced activity in the PFC may affect pain
sensation is unknown, and the mechanisms by which the medial
PFC (mPFC) and its prelimbic subregion participate in pain pro-
cessingare incompletely understood. Importantly, howemotional
responses topainstimuli aregenerated in thebrain remainsoneof
the mysteries in the field of neuroscience.
GABAergic interneurons form local circuits and control
neuronal activities via GABA release. Parvalbumin-positive
GABAergic basket cells synapse onto the somata and proximal
dendrites of pyramidal cells, and their perisomatic inhibition reg-
ulates spike timing and synchronization of large populations of
pyramidal cells. GABAergic modulation of pain transmission
has been extensively investigated in the spinal cord, but its
modulatory effect at the supraspinal level is only emerging (Gross
et al., 2007; Hauck et al., 2007; LaGraize and Fuchs, 2007; Narita
et al., 2011). Here, we used optogenetic approaches in conjunc-
tion with a spared nerve injury neuropathy model to investigate
the role of parvalbumin (PV)-positive interneurons (PVINs) in
pain modulation. Our results reveal that feed-forward inhibition
is the mechanism whereby PVINs modulate the activity of the
mPFC and, ultimately, the perception of pain.RESULTS
Hypoactivity in Prelimbic Layer V Pyramidal Neurons of
Neuropathic Mice
To examine how peripheral neuropathy affects neuronal activity
in the prelimbic area, we performed whole-cell patch-clamp re-
cordings from layer V pyramidal neurons in PFC slices from adult
SHAMmice and frommicewith spared nerve injury (SNI) 10 days
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Figure 1. Neuronal and Synaptic Activity
Recorded in Prelimbic Layer V Pyramidal
Neurons in SNI and SHAM Mice
(A) Representative recording of action potential
firing of a pyramidal cell in response to current
injection (200 pA) in brain slices from SHAM (left)
and SNI (right) mice. The inset shows the experi-
mental design for (A and B) (the triangle indicates
pyramidal cell).
(B) Firing frequency in pyramidal cells as a func-
tion of depolarizing current injection. Note the
decrease in excitability of pyramidal neurons in
SNI mice and its reversal by bicuculline (BIC;
10–20 mM). *p < 0.05; **p < 0.01; ***p < 0.001.
(C and D) Amplitudes of evoked inhibitory synaptic
events in slices from SHAM and SNI mice, re-
corded (C) in the presence of APV (50 mM) and
DNQX (20 mM) to block excitatory synaptic trans-
mission or (D) in the absence of synaptic blockers.
The inset shows the experimental configuration for
(C and D) (the triangle indicates pyramidal cell, the
circle indicates GABA neuron, and the red light-
ning symbol indicates the position of the electrical
stimulating electrode). *p < 0.05; **p < 0.01.after surgery (Figure 1). No difference was observed in resting
membrane potential and action potential threshold of layer V py-
ramidal neurons from brain slices obtained from SHAM and SNI
mice (Figures S1A and S1B). However, the input resistance was
significantly lower in neuropathic mice than in SHAM control
mice (p = 0.0012, unpaired t test) (Figure S1C). The current
required to induce action potential firing was increased in SNI
mice (p = 0.0310, unpaired t test) (Figure S1D). Excitability of
layer V pyramidal neurons was decreased in SNI mice (Fig-
ure 1B). Importantly, the GABA-A receptor blocker bicuculline
(10–20 mM) reversed the low activity in pyramidal neurons, indi-
cating that the observed injury-induced reduction in prelimbic
output neuron activity is mediated by enhanced GABAergic
inputs (Figure 1B).
Altogether, these data indicate that peripheral nerve injury
triggers a long-term change in GABAergic signaling in the prelim-
bic area.
Enhanced GABA Release in Slices from SNI Mice Is
Mediated by Glutamatergic Inputs
To test whether inhibitory synaptic transmission is altered in
neuropathic pain, we first recorded miniature inhibitory postsyn-
aptic currents (mIPSCs) in prelimbic layer V pyramidal neurons
in the presence of tetrodotoxin (TTX) (1 mM). No difference was
observed in the frequency (Figure S1E), amplitude (Figure S1F),
and decay time (Figure S1G) of mIPSCs between SNI and
SHAM mice. Furthermore, no difference was observed in the
input-output relationship of evoked IPSCs (eIPSCs) between
neuropathic and SHAM mice in the presence of APV (50 mM)Cell Reports 12, 752–75and DNQX (20 mM) to block excitatory
synaptic transmission (Figure 1C). How-
ever, in the absence of excitatory synaptic
blockers, the slope of the input-output
relations was enhanced in slices fromSNI mice compared to the SHAM so that the peak amplitude of
eIPSCs was increased over the range of stimuli applied (Fig-
ure 1D; two-way ANOVA). Hence, enhanced excitatory synaptic
transmissionmediates the increasedGABAergic input onto pyra-
midal cells. Recordings in enhanced yellow fluorescent protein
(eYFP)-expressing PVINs from Channelrhodopsin 2 (ChR2)
mice revealed that the basic neuronal properties of PVINs are
similar in SHAM and SNI animals (Table S1). Spontaneous excit-
atory synaptic input onto PVINs (in the absence of TTX) was
increased in nerve-injured mice as evident from an increased
frequency of spontaneous excitatory postsynaptic events (Fig-
ure S1H), whereas the amplitude was unaltered (Figure S1I).
These data support an enhanced excitatory synaptic input onto
PVINs in the prelimbic cortex in nerve-injured mice.
Modulation of PVIN Activity in PFC Slices via
Optogenetics
PVINs may participate in pain perception at the cortical level
(Cardin et al., 2009; Gross et al., 2007; Hauck et al., 2007). To
determine whether PVINs play a similar role at the circuit level
in controlling pain-related information in the PFC, B6;129S-Gt
(ROSA)26 Sortm32(CAG-COP4*H134R/eYFP) Hze/J mice were crossed
with PV Cre animals to induce selective expression of eYFP-
tagged ChR2-H134R in PV-positive GABAergic neurons (Fig-
ure S2). PVIN neuronal activity could, thus, be manipulated in
slice recordings via blue (473-nm) light. As shown in Figures
2A–2C, whole-cell recordings from eYFP-expressing neurons
reveal that a blue light evoked large inward current (375 ±
45 pA; n = 5) (Figure 2B) and high-frequency firing (Figure 2C).9, August 4, 2015 ª2015 The Authors 753
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Figure 2. Optical Activation of PVINs in PFC
Slices
(A) Diagrammatic location of brain slice electro-
physiological recording in prelimbic layer V. Dots
denote layer V neurons. PrL, prelimbic.
(B) Blue light evoked whole-cell current recorded
in eYFP-tagged ChR2-expressing neurons.
(C) Current clamp recordings under either contin-
uous blue-light stimulation or in response to blue-
light stimuli delivered at various frequencies. The
blue-light-evoked pulse-locked cell firing exhibits
high temporal fidelity up to 100 Hz, confirming
the expression and function of ChR2 in fast-
spiking interneurons. The inset on upper right
shows the experimental configuration for (B and C)
(the circle indicates PVIN, and the cartoon of the
fiberoptic tip emitting blue light indicates the locus
of optical stimulation).
(D and E) Effect of blue-light stimulation (D) on
input resistance and (E) on current threshold in
layer V pyramidal cells. Numerals indicate number
of experiments. Error bars indicate SEM. *p < 0.05.
(F) Firing frequency of layer V pyramidal cells before
and after stimulation of PVINs with blue light. 10–
20 mMbicuculline (Bic) blocks the effect of blue light
on firing frequency. Light stimulation was carried
out using a light-emitting diode at a wavelength of
473 nm. The inset shows the experimental config-
uration for (D–F) (the circle indicates PVIN, the
triangle indicatespyramidal cells, and theblue-light-
emitting tip indicates the locus of optical stimula-
tion). Numerals indicate number of experiments.
Error bars indicate SEM. *p < 0.05; **p < 0.01.
(G) Example of yellow-light-induced outward
current and membrane hyperpolarization in a pu-
tative PVIN expressing Arch3. The inset shows
the experimental configuration for (G and H) (the
circle indicates PIVN, the yellow-light-emitting
tip indicates the locus of optical stimulation in
(G and H), and the red lightning symbol indicates
the locus of electrical stimulation in (H).
(H) Effect of yellow light (589 nm) on electrically
evoked firing in a putative PVIN.
(I) Action potential half-width in light-sensitive
and light-insensitive (i.e., pyramidal) neurons.
Numerals indicate n for each group. Error bars
indicate SEM. The asterisks denote statistical
significance at the 0.001 level.
(J) Representative voltage clamp recording from a
layer V pyramidal cell showing the effect of yellow
light inhibition of PVINs on electrically evoked
inhibitory postsynaptic current (eIPSC; Vh, 0 mV).
The inset shows the experimental configuration (the
triangle indicates pyramidal cell, the circle indicates
PVIN, the yellow-light-emitting tip indicates the
locus of optical stimulation, and the red lightning
symbol indicates the locus of electrical stimulation).
(K) Latencies of polysynaptic input-mediated eIPSCs compared to monosynaptic eIPSCs that were evoked by directly stimulating the PVINs close to the
recording electrode (layer V of prelimbic cortex) in the presence of APV and DNQX.
(L–O) Family of eIPSCs recorded in prelimbic layer V pyramidal cells in response to electrical stimulation of pathways bypassing infralimbic cortex (with
stimulating electrode positioned in layer V of the infralimbic cortex) (L) before, (M) during, and (N) after yellow-light (589 nm) activation of Arch3 in PVINs or (O)
after inhibition of eIPSCs by addition of APV (50 mM) and DNQX (20 mM) in the bath.Light stimulation induced strictly pulse-locked action potential
firing in these neurons (Figure 2C), with high temporal fidelity
up to 100 Hz, thus confirming the expression and function of754 Cell Reports 12, 752–759, August 4, 2015 ª2015 The AuthorsChR2 in fast-spiking interneurons. Light-evoked activation of
these neuronsmediated a significant reduction in cell input resis-
tance of pyramidal cells (Figure 2D; p = 0.0284) and increased
the current threshold for action potential firing (Figure 2E;
p = 0.0388). The slope of the relationship between the average
firing frequency and injected current was also decreased in the
presence of blue light (Figure 2F) but reversed after the addition
of bicuculline (20 mM) (Figure 2F; two-way ANOVA).
To inhibit GABAergic signaling, we crossed B6;129S-
Gt(ROSA)26Sortm35.1 (CAG-aop3/GFP)Hze/J (ai35D) mice with PV
Cre mice for selective expression of GFP-tagged archaerhodop-
sin-3 (Arch3) in PVINs. Yellow-light illumination of PFC slices
from these mice induced a strong outward current and hyperpo-
larization in GFP-expressing neurons (Figure 2G) and terminated
action potential firing during a high-frequency burst evoked by
electrical stimulation (Figure 2H). The key feature of PVINs is their
short action potential duration and fast-spiking action potential
phenotype. A comparison of action potential firing in light-sensi-
tive and light-insensitive neurons reveals that light-sensitive
neurons exhibit a shorter action potential half-width than light-
insensitive neurons (Figure 2I) (unpaired Student’s t test), consis-
tent with the correct expression of Arch3 in PVINs.
PVINs Mediate Feed-Forward Inhibition of Layer V
Pyramidal Cells
The data in Figure S1H indicate an enhancement of synaptic in-
puts onto PVINs. To directly activate these inputs, we placed a
stimulating electrode at layer V of the prelimbic cortex and per-
formed whole-cell recordings in layer V pyramidal cells in the
prelimbic cortex (Figure 2J). To block action potential firing and
improve space clamp in pyramidal cells, we used a cesium-
based intracellular solution containing 5 mM QX-314. Under
these conditions, low electrical stimulation (at double the
threshold intensity) induced eIPSCs in layer V pyramidal neurons
(at a holding potential of 0 mV) (Figure 2J; n = 5). Yellow-light illu-
mination of slices expressing Arch3 reversibly suppressed
eIPSC activity (Figure 2J; n = 5), indicating that the observed
inhibitory events originated from PVINs. The eIPSCs were
blocked by bicuculline (20 mM), suggesting that these inhibitory
events were mediated by GABA-A receptors (data not shown).
These directly evoked IPSCs displayed the features of a mono-
synaptic input, as evident from the short latency and low degree
of variation (Figure 2K). When the stimulating electrode was,
instead, placed in the infralimbic region to activate synaptic in-
puts onto the PVINs, the latency of eIPSCs in the pyramidal cells
showed a larger variation, as expected from a polysynaptic pro-
cess (Figures 2L and 2N). They were completely blocked by yel-
low-light illumination (Figure 2M) and by the excitatory synaptic
blockers APV (50 mM) and DNQX (20 mM), suggesting that the
eIPSCs are mediated by glutamatergic (excitatory) inputs onto
the PVINs (Figure 2O; n = 5). Furthermore, electrically evoked
eIPSCs failed to follow 20-Hz electrical stimulation (data not
shown).
Altogether, these experiments indicate that PVINs receive
excitatory inputs and then mediate feed-forward inhibition of
layer V pyramidal cells in the prelimbic area.
Photomodulation of PVINs Affects Pain Responses in
Nerve-Injured Animals
To ascertain the role of PVINs in pain perception, we assessed
mechanical and thermal withdrawal thresholds of ChR2- andArch3-expressing mice in the presence or the absence of light
stimulation of the prelimbic area. This was done by implantation
of an optic fiber into the prelimbic cortex, followed by optoge-
netic stimulation. Correct targeting of the prelimbic area was
verified after behavioral studies with cryosectioning and c-Fos
immunohistochemistry (Figures S3 and S4). The locations of
the optic fiber tips in all animals examined were at the upper
part of the prelimbic cortex, indicating that we, indeed, targeted
the prelimbic cortex. The c-Fos immuno-stained nuclei in brain
slices obtained from the ChR2- or Arch3-expressing animals
were mainly localized in the prelimbic cortex, especially in layer
V underneath the tip of the optic fiber when examined in the
ventral-dorsal axis. Very few c-Fos-positive cells were observed
at coronal sections 0.24 mm away (anterior) from the center
plane through the optic fiber, suggesting that c-Fos-stained
nuclei are exclusively distributed in the prelimbic cortex
(Figure S4). Many c-Fos-stained nuclei were observed inside
eYFP-fluorescent cells in ChR2-expressing mice, indicating
that the blue laser directly activated the ChR2-expressing
GABA interneurons (Figure S3A). Stained nuclei were rarely
seen inside GFP fluorescent cells in Arch3-expressing mice,
suggesting that PVIN activity, and thus c-Fos expression, are
inhibited by yellow light and that the activated neurons are
mainly non-fluorescent pyramidal cells (Figure S3B).
Pain sensitivity in optogenetically stimulated animals was
determined by measuring thermal withdrawal latency and me-
chanical withdrawal thresholds. In ChR2-expressing mice, ani-
mals subjected to SNI developed thermal andmechanical hyper-
algesia, as demonstrated by a significant decrease in withdrawal
latency and mechanical threshold (p < 0.001, two-way ANOVA)
when compared to either the contralateral paws or the SHAM
group (Figures 3A and 3B). Surprisingly, we observed that
blue-light stimulation (40 Hz, 10-mswidth) of SNI-injured animals
exacerbated both thermal (Figure 3A) andmechanical (Figure 3B)
hyperalgesia in the ipsilateral paw. Similarly to ChR2-expressing
mice, SNI triggered both thermal (Figure 3C) and mechanical
(Figure 3D) hyperalgesia (p < 0.001, two-way ANOVA) in the
ipsilateral paws of Arch3-expressing mice when compared to
contralateral paws and the SHAM group. As shown in Figures
3C and 3D, yellow-light stimulation reversed both thermal and
mechanical hyperalgesia.
Altogether, these data indicate that PVINs in the prelimbic
cortex participate in pain information processing and that opto-
genetic manipulation of the activity of these neurons allows for
bidirectional modulation of sensory pain sensitivity.
Modulation of Affective Pain by PVIN Activity
Pain has both a sensory component and an emotional compo-
nent that contribute to its perception. However, the mechanism
of emotional pain modulation in the PFC is still elusive. To
address this issue, we used a conditioned place preference
(CPP) paradigm—a well-established, stimulus-independent,
voluntary behavioral test to assess how local circuit neurons
modulate pain behavior in free-moving animals (He et al., 2012;
King et al., 2009; Park et al., 2013). The test is based on the
fact that pain in animals, similar to human pain experience, is
aversive and produces a strong motivational drive to seek relief
(Craig, 2002), and relief of pain caused by a specific treatment isCell Reports 12, 752–759, August 4, 2015 ª2015 The Authors 755
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Figure 3. Effects of In Vivo Optogenetic
Modulation of PVIN Activity on Sensory
Pain Behavior
(A and B) Effect of ChR2 activation of PVINs in
SHAM and SNI mice on (A) thermal withdrawal
latency and (B) mechanical withdrawal threshold
for the paws ipsi- and contralateral (Ipsi and
Contra, respectively) to the surgery. *p < 0.05.
**p < 0.01; ***p < 0.001; NS, not significant.
(C and D) Effect of Arch3 activation of PVINs in
SHAM and SNI mice on (C) thermal withdrawal
latency and (D) mechanical withdrawal threshold
for the paws ipsi- and contralateral to the surgery.
**p < 0.01; ***p < 0.001.
Numerals indicate n for each group.rewarding and can produce CPP selectively with nerve injury (but
not SHAM) in both rats and mice (He et al., 2012; King et al.,
2009; Park et al., 2013). Animals implanted with an optic fiber
cannula (separate from threshold measurement groups) were
attached to a DPSS laser via a patch cable and rotary joint and
were subjected to the 5-day CPP testing. Animals first under-
went a 2-day pre-conditioning where they had unrestricted ac-
cess to all three chambers of a CPP box (Figures 4A and 4B).
This was followed by a 2-day conditioning phase in which
light-stimulation paradigms (blue light: 40 Hz, 10ms; yellow light:
continuous) were paired with restricted access to one of the two
side chambers (horizontally and vertically striped walls; see Fig-
ure 4B), whereas no stimulation was paired with the opposing
chamber in alternate morning and afternoon sessions.
After conditioning, the animals were subjected to a testing
phase in which they were free to choose a particular chamber.
On the testing day, SNI, but not SHAM, animals developed
chamber preference and aversion. Thus, SNI animals spent
less time in the blue-light-conditioned chamber and spent
more time in the yellow-light-conditioned chamber compared
to their respective SHAM counterparts (Figures 4C and 4D;
unpaired Student’s t test). These effects are not caused by
impaired or enhanced locomotion or impaired memory, because
light stimulation did not change the number of midline crossings
to the other chamber (Figure 4E). Furthermore, neither blue nor
yellow light influenced the ambulatory behavior of mice when
tested in an open-field apparatus (data not shown). The change
in CPP score was greater in response to Arch3 activation756 Cell Reports 12, 752–759, August 4, 2015 ª2015 The Authorscompared to the effect observed after
ChR2 activation (Figure 4D; compare
with Figure 4C). This fits with the observa-
tions in Figure 3 showing that blue light
mediated only a small (albeit statistically
significant) reduction in pain threshold,
whereas yellow light strongly inhibited
pain responses. To further evaluate the
effect of PVIN activity on affective pain
behavior, we performed a place escape/
avoidance paradigm to measure acute
affective pain response to stimuli (supra-
threshold mechanical stimulation; see
Experimental Procedures), a differenttest that does not rely on the reward system and does not
need associative training. We did not observe enhanced escape
behavior with blue-light stimulation (activation of PVINs) via
ChR2, possibly because of a ceiling effect in this test (Figure 4F).
Importantly, however, yellow-light stimulation (inhibition of
PVINs via Arch3) dramatically attenuated escape behavior, as
animals spent less time in the bright-walled chamber (Figure 4G).
Altogether, these data indicate that PVINs in the prelimbic area
regulate emotional responses to pain.
DISCUSSION
The PFC is a crucial integration center that processes inputs
from the hippocampus (Jay and Witter, 1991; Preston and Ei-
chenbaum, 2013), amygdala (Neugebauer et al., 2009; Phelps
and LeDoux, 2005), and nucleus accumbens (Groenewegen
et al., 1999; Navratilova and Porreca, 2014) to produce a
behavioral output in response to environmental changes. One
such influence is nerve injury that gives rise to chronic pain.
Here, we found that peripheral nerve injury inhibits pyramidal
cell firing in the prelimbic area of the PFC, as a result of
feed-forward inhibition from excitatory inputs via PV-express-
ing GABAergic interneurons. Activation of inhibitory Arch3
or excitatory ChR2 in PVINs respectively decreased and
increased pain responses and, accordingly, manifested itself
in changes of thermal and mechanical sensory threshold and
in changes of CPP and place escape/avoidance scores in freely
moving mice. Thus, our findings demonstrate a crucial role of
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Figure 4. Effects of Optogenetic Modula-
tion of PVIN Activity on Emotional Pain
Behavior
(A) A 5-day protocol for the CPP paradigm (see
details in Experimental Procedures).
(B) A video capture of a mouse during the CPP
experiment to illustrate the design of the CPP
chamber and the looseness of the optical fiber.
(C and D) Difference scores for SHAM and SNI
mice conditioned either by activation of (C)
ChR2 or (D) Arch3 in PVINs. *p < 0.05. Error bars
indicate SEM.
(E) Effects of activation of ChR2 or Arch3 in PVINs
on numbers of crossings in SNI mice. Numbers
indicate n for each group. Error bars indicate SEM.
NS, not significant.
(F and G) Effects of activation of (F) ChR2 or (G)
Arch3 in PVINs on the percentage of time spent in
the light portion of the place escape/avoidance
chamber during the 30-min test period for SHAM
and SNI mice. Yellow-light stimulation reduced
escape/avoidance behavior. Numerals indicate
numbers of experiments for each group. Error bars
are SEM. *p < 0.05. **p < 0.01.the prelimbic area in pain perception and that modulation of
PVIN activity bidirectionally altered both sensory and emotional
pain perception.
Our data demonstrate that nerve injury causes a low neuronal
activity state in the prelimbic cortex and that there is a causal link
between this activity and neuropathic-pain-related behaviors.
This finding is consistent with reduced PFC activity in patients
with prolonged surgical dental pain (Derbyshire et al., 1999),
persistent pain in rheumatoid arthritis (Jones and Derbyshire,
1997), and ulcerative colitis (Mayer et al., 2005). In our slice re-
cordings, we presumably stimulated pathways bypassing the
infralimbic cortex (including monosynaptic inputs from the
amygdala) as a tool to drive feed-forward inhibition of layer V py-
ramidal neurons via PVINs (Gabbott et al., 2006; Ji et al., 2010;
Orozco-Cabal et al., 2006). This process was altered in SNI ani-
mals, and this effect depended critically on enhanced excitatory
synaptic transmission involving ionotropic glutamate receptors
in PVINs. Our observation supports the notion that there is an
altered PVIN activity in the prelimbic cortex of nerve-injured
mice, which mediates the low activity in output neurons and,
therefore, the altered pain behavior.
The specificity of ChR2 and Arch3 expression in PVINs is
of critical importance toward our ability to properly interpretCell Reports 12, 752–75our experimental results. We determined
that all sampled eYFP-fluorescent neu-
rons (n = 11) in ChR2-expressing animals,
and all GFP-fluorescent neurons (n = 5)
in Arch3-expressing animals, have multi-
shaped morphology (data not shown)
and exhibited high-frequency firing with
short action potential half-width. These
are the classical hallmarks of fast-spiking
PVINs. The observation that the vast
majority of eYFP-expressing neuronsalso express PV protein further supports the specificity of our
optogenetic approach.
The observation in our CPP experiments reveals the presence
of an aversive state as the result of ongoing pain in SNI animals.
Blue-light-mediated activation of PVIN enhances pain behavior
and the aversive state, whereas, yellow-light-mediated inhibition
of PVIN alleviates pain and the aversive state. It is believed that
relief of pain causes reward via a negative reinforcement mecha-
nismdrivenbya strongmotivation to seekpain relief (Craig, 2002;
He et al., 2012; King et al., 2009). Therefore, it is important to
consider the possibility that our optogenetic manipulations did
not modulate pain perception per se but affected the reward-
seeking process directly. However, this is unlikely to be the
case for the following reasons. First, optogenetic manipulation
did not change CPP scores in SHAM-operated animals, but it
altered CPP scores in mice with persistent pain, thus clearly link-
ing the CPP scores to a neuropathic pain state. Second, optoge-
netic stimulation and inhibition of PVINs not only altered CPP
scores but also affected sensory pain behavior in SNI animals.
A distinction between effects on emotional aspects of pain and
learning andmemory is a challenge with currently available para-
digms for measuring emotional pain (Tappe-Theodor and Kuner,
2014). To address this issue, we used a place escape/avoidance9, August 4, 2015 ª2015 The Authors 757
(PEA) paradigmas an additionalmeasure of emotional aspects of
pain processing (LaBuda and Fuchs, 2000; LaGraize and Fuchs,
2007). The most parsimonious explanation for the observed PEA
behavior is that it arises from aversion to the stimulation para-
digm. Although both CPP and PEA paradigms might be related
to certain types of memory, the PEA test does not require asso-
ciative training and long-term memory as the CPP test does. It
is possible thatmanipulation of PVINs, e.g., yellow-light inhibition
of PVIN via Arch3, may have disrupted the acquisition of avoid-
ance behavior or impaired working memory. However, if this
were the case, then after stimulation of the ipsilateral paw, the an-
imal would temporarily escape to the other side of box in the PEA
test. The animal would then return to the preferred side of the
chamber and again receive the noxious stimuli. This repetitive
process would be expected to result in an increased frequency
in midline crossings, which was not observed (data not shown).
Therefore, we conclude thatmemory is unlikely to be a confound-
ing factor in the interpretation of our results from the PEA
paradigm. The neural representation of the attenuation of PEA
behavior is unknown. However, it is likely that yellow-light-
induced pain relief involves the reciprocal connections of
prelimbic cortex with other limbic system and brainstem struc-
tures. Information that is transmitted to the prelimbic cortex
may, in turn, be used in the descending pain modulatory control
(Lee et al., 2015).
Understanding the emotional components of chronic pain is
complex, because it involves multiple brain structures that proj-
ect to the mPFC. It is the mPFC that is the critical output struc-
ture that ultimately determines behavioral response (McDonald
and Hong, 2013; Neugebauer et al., 2009; Simons et al., 2014).
In this context, our experiments reveal a critical role of PVINs
in the processing of pain information, with regard to both sensory
and affective aspects of pain. The potent inhibition of pain re-
sponses by Arch3 suggests possible strategies for therapeutic
intervention in chronic pain states, including neuropathic pain.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Experi-
mental Procedures.
Animals
Adult male C57BL/6 (wild-type) mice were purchased from Jackson Labora-
tories. ChR2- or Arch3-expressing mice were generated by crossing PV-Cre
knockin mice with ai32 and ai35D mice, respectively (Jackson Laboratories).
Electrophysiology
Acute brain slices were prepared from various mouse strains by cutting coro-
nal sections that were kept at room temperature until used for whole-cell
patch-clamp recordings. To examine the input-output relationship of inhibitory
synaptic transmission, we placed a concentric bipolar stimulating electrode
adjacent to the recording electrode (300–500 mm) in layer V of the prelimbic
cortex. For the eIPSC recordings in Figures 2L–2O, we used a low-stimulus in-
tensity at twice the threshold value to prevent unspecific current spreading,
with the stimulating electrode placed in layer V of the infralimbic cortex
(600–800 mm away from recording electrode).
Optogenetics
ChR2- and Arch3-expressing neurons were stimulated, respectively, with blue
(473 nm) and yellow (589 nm) light in both slice recording and behavioral exper-
iments. In some brain slice recordings, we also used an LED blue-light source758 Cell Reports 12, 752–759, August 4, 2015 ª2015 The Authors(473 nm) to activate GABA neurons. Light was delivered to brain slices in a
focal area (1 mm2) around the recording electrode. Fiberoptic cannulae with
a 200-mm core fiber were used for brain implantation in the prelimbic area of
the PFC under isofluorane anesthesia. To mimic gamma frequency in behav-
ioral experiments, GABA neurons were activated by blue-light pulses (10 ms)
at 40 Hz (Cardin et al., 2009), whereas GABA neurons were inhibited using
continuous solid yellow light.
Measurements of Pain Threshold in Mice
Measurements of mechanical and thermal withdrawal threshold/latencies
were taken between 2 and 3 weeks after nerve injury and under optogenetic
stimulation. Pain assessments were performed as described by us previously
(Garcı´a-Caballero et al., 2014).
CPP and PEA Testing
CPP experiments started with a 2-day pre-conditioning phase, in which the
animal with a patch cable attached to the implanted cannula was placed in a
three-chamber CPP box with access to all chambers for 30 min each day.
Mice then underwent a 2-day conditioning phase. In the morning session,
blue or yellow laser stimulation was paired with one of the two side chambers
for 15 min, while non-stimulation was paired with the opposing side chamber
for 15 min 4 hr later in the afternoon. On the test day, mice were treatment-free
and placed in the middle of the CPP box with free access to all chambers for
15 min, and the time spent in each chamber was converted to a CPP score.
PEA testing (LaBuda and Fuchs, 2000; LaGraize and Fuchs, 2007) was per-
formed 2–3 weeks after brain cannula implantation and 3–4 weeks after SHAM
or SNI surgery. Animals were placed within a PEA box, with a dark area and a
light area, that was positioned on top of a mesh screen. After habituation,
suprathreshold mechanical stimulation was applied to the lateral plantar sur-
face of the hindpaws at 15-s intervals. The mechanical stimulus was applied
to the left paw (ipsilateral to injury) when the animal was within the dark area
of the test chamber and applied to the right paw (contralateral to injury)
when the animal was within the light area of the test chamber. Data were
expressed as percentage of time in the light chamber.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.07.001.
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